The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 10, 2026
Filed:
May. 14, 2021
Applicant:
Fujian Akeylink Biotechnology Co., Ltd., Fujian, CN;
Inventors:
Wenqiang Wu, Fujian, CN;
Dong Zhang, Fujian, CN;
Zhiqiang MA, Fujian, CN;
Yixin Zhou, Fujian, CN;
John Mao, Fujian, CN;
Zhigan Jiang, Shanghai, CN;
Jing Wang, Shanghai, CN;
Haiying He, Shanghai, CN;
Assignee:
FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD., Fujian, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/554 (2006.01); A61K 31/513 (2006.01); A61K 31/522 (2006.01); A61K 31/5365 (2006.01); A61K 31/553 (2006.01); A61K 31/675 (2006.01); A61K 45/06 (2006.01); A61P 31/20 (2006.01);
U.S. Cl.
CPC ...
A61K 31/554 (2013.01); A61K 31/513 (2013.01); A61K 31/522 (2013.01); A61K 31/5365 (2013.01); A61K 31/553 (2013.01); A61K 31/675 (2013.01); A61K 45/06 (2013.01); A61P 31/20 (2018.01);
Abstract
A combination comprising a tricycle compound and use thereof in the preparation of a medicament for treating HBV. The combination is a combination of a compound of formula (I) or a pharmaceutically acceptable salt thereof and any one drug in the following groups a-c: a. a hepatitis B surface antigen inhibitor, b. a reverse transcriptase inhibitor, and c. a hepatitis B surface antigen inhibitor and a reverse transcriptase inhibitor.